(Q54325677)

English

Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.

scientific article published in September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results. (English)

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

16

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

2

object named as

Håkan Arheden

1 reference

Europe PubMed Central

27 May 2018

Jan Erik Nordrehaug

20

object named as

Jan Erik Nordrehaug

1 reference

Europe PubMed Central

27 May 2018

Jean-Luc Dubois-Randé

9

object named as

Jean-Luc Dubois-Randé

1 reference

Europe PubMed Central

27 May 2018

1

object named as

Dan Atar

1 reference

Europe PubMed Central

27 May 2018

author name string

Alain Berdeaux

3

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Jean-Louis Bonnet

4

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Marcus Carlsson

5

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Peter Clemmensen

6

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Valérie Cuvier

7

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Nicolas Danchin

8

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Henrik Engblom

10

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

David Erlinge

11

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Hüseyin Firat

12

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Sigrun Halvorsen

13

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Henrik Steen Hansen

14

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Wilfried Hauke

15

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Sasha Koul

17

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Alf-Inge Larsen

18

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Philippe Le Corvoisier

19

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Franck Paganelli

21

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Rebecca M Pruss

22

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Hélène Rousseau

23

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Sophie Schaller

24

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Giles Sonou

25

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Vegard Tuseth

26

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Julien Veys

27

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Eric Vicaut

28

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Svend Eggert Jensen

29

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

publication date

1 September 2014

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

European Heart Journal

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

36

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

2

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

112-119

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Acute heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Exenatide reduces final infarct size in patients with ST-segment-elevation myocardial infarction and short-duration of ischemia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

A pilot study of rapid cooling by cold saline and endovascular cooling before reperfusion in patients with ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Reduction of infarct size by ischaemic post-conditioning in humans: fact or fiction?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Cardioprotection: chances and challenges of its translation to the clinic

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

The mitochondrial permeability transition pore and ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

TRO40303, a new cardioprotective compound, inhibits mitochondrial permeability transition.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Assessment of myocardium at risk with contrast enhanced steady-state free precession cine cardiovascular magnetic resonance compared to single-photon emission computed tomography

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Myocardium at risk by magnetic resonance imaging: head-to-head comparison of T2-weighted imaging and contrast-enhanced steady-state free precession

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Automated quantification of myocardial infarction from MR images by accounting for partial volume effects: animal, phantom, and human study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Rationale and Design of the MITOCARE Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHU331

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHU331

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

1 reference

Europe PubMed Central

27 May 2018

http://europepmc.org/abstract/MED/25179768

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54325677&oldid=2084524782"